Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.10
Delayed Data
As of 1:41pm ET
 +0.05 / +1.64%
Today’s Change
2.40
Today|||52-Week Range
4.08
+19.23%
Year-to-Date
No recent news for AcelRx Pharmaceuticals Inc.

Today’s Trading

Previous close3.05
Today’s open3.15
Day’s range3.05 - 3.15
Volume80,565
Average volume (3 months)213,521
Market cap$138.3M
Dividend yield--
Data as of 1:41pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-58.33%
Earnings growth (this year)-7.89%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-9.89%
P/E ratioNM
Price/Sales6.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SBBPStrongbridge Biophar...+0.10+2.56%
--EcoGreen Internation...0.000.00%
ALBOAlbireo Pharma Inc-0.21-0.94%
MDWDMediwound Ltd+0.03+0.39%
Data as of 1:42pm ET, 03/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$17.4M
Annual profit (last year)-$43.2M
Net profit margin-248.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Vincent J. Angotti
CFO &
Head-Business Development
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs